Barium sulfate (BaSo 4) was considered to be poorly-soluble and of low toxicity, but BaSO 4 NM-220 showed a surprisingly short retention after intratracheal instillation in rat lungs, and incorporation of Ba within the bones. Here we show that static abiotic dissolution cannot rationalize this result, whereas two dynamic abiotic dissolution systems (one flow-through and one flow-by) indicated 50% dissolution after 5 to 6 days at non-saturating conditions regardless of flow orientation, which is close to the in vivo half-time of 9.6 days. Non-equilibrium conditions were thus essential to simulate in vivo biodissolution. Instead of shrinking from 32 nm to 23 nm (to match the mass loss to ions), TEM scans of particles retrieved from flow-cells showed an increase to 40 nm. Such transformation suggested either material transport through interfacial contact or Ostwald ripening at super-saturating conditions and was also observed in vivo inside macrophages by high-resolution TEM following 12 months inhalation exposure. The abiotic flow cells thus adequately predicted the overall pulmonary biopersistence of the particles that was mediated by non-equilibrium dissolution and recrystallization. The present methodology for dissolution and transformation fills a high priority gap in nanomaterial hazard assessment and is proposed for the implementation of grouping and read-across by dissolution rates. Knowledge about pulmonary retention kinetics of inhaled particles is an essential element of hazard assessment and of understanding the mechanisms by which adverse health outcomes may occur. Barium sulfate was generally assumed to be poorly-soluble and of low toxicity unless delivered at high concentrations over an extended period 1,2. However, Konduru and colleagues reported that intratracheally instilled 131 BaSO 4 NM-220 exhibited a lung retention half-time of only 9.6 days in rats and that 131 Ba was incorporated into the bones, suggesting nanoparticle dissolution and/or translocation to extrapulmonary sites 3. A subsequent 90-day inhalation study in rats with a high concentration of aerosolized BaSO 4 NM-220 (50 mg/m 3) 4 revealed no signs of lung overload and a retention half-time of 56 days, which is close to the normal range for the rat lung 4. A two-year rat inhalation study with BaSO 4 NM-220 (50 mg/m 3), however, demonstrated an increase of retained Ba in the lung during the first year of exposure, after which a steady-state was achieved 5. Since significant Ba accumulation in bone and bone marrow was also observed and, given that the measurements of Ba distribution [1-3] provide no information about its physicochemical characteristics, the complex in vivo dissolution and/or transformation of BaSO 4 secondary to inhalation exposure require more detailed investigation.